Sunday - January 26, 2025

Category Archives: Marketing & Sales

Migraine Pipeline 2024: Key Developments, Emerging Therapies, and Clinical Trials Detailed Analysis by DelveInsight | GlaxoSmithKline, Merck & Co., Inc., Pfizer, Bausch Health, Amgen, Abbvie Inc

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Migraine pipeline constitutes 30+ key companies continuously working towards developing 30+ Migraine treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.   … Continue reading →

Acute Ocular Pain Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Formosa Pharmaceuticals, Surface Ophthalmics, SPARC, Visiox

The Key Acute Ocular Pain Companies in the market include – Oculis, Formosa Pharmaceuticals, Surface Ophthalmics, Sun Pharma Advanced Research Company Ltd (SPARC), Ocular Therapeutix, Kala Pharmaceuticals, Sun Pharmaceutical, Bausch & Lomb, and others.   DelveInsight’s “Acute Ocular Pain Market … Continue reading →

Hyperopia Market on Track for Major Expansion by 2034, According to DelveInsight | Vyluma, Center For Excellence In Eye Care, Technolas Perfect Vision GmbH

The Key Hyperopia Companies in the market include – Vyluma, Center For Excellence In Eye Care, Technolas Perfect Vision GmbH, and others.   DelveInsight’s “Hyperopia Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Hyperopia, historical … Continue reading →

Chronic Pain Associated With Painful Diabetic Neuropathy Market Growth Projections 2023-2032: DelveInsight Analysis | AstraZeneca, Regenacy Pharma, Nevro Corp., Erchonia Corporation

The Key Chronic Pain Associated With Painful Diabetic Neuropathy Companies iin the market include – AstraZeneca, Regenacy Pharmaceuticals, Nevro Corp., Erchonia Corporation, and others   DelveInsight’s “Chronic Pain Associated With Painful Diabetic Neuropathy Market Insights, Epidemiology, and Market Forecast-2032″ report … Continue reading →

Eosinophilic Esophagitis Pipeline 2024: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | Bristol Myers Squibb, Ellodi Pharma, AstraZeneca, Kyowa Hakko Kirin

Las Vega (Nevada), United States //— As per DelveInsight’s assessment, globally, Eosinophilic Esophagitis pipeline constitutes 18+ key companies continuously working towards developing 20+ Eosinophilic Esophagitis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments … Continue reading →